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Abstract
Background: There is a rapid emergence of multiple resistant gram-negative bacteria due to overuse of antibiotics
in the treatment of infections. Biofilms consist of polymicrobial communities that survive the host’s defense system.
The key bacteria in biofilms are slow growing and support an attachment and rapid growth of other microorganisms.
Current antimicrobial strategies often fail due to poor diagnosis of key pathogens in biofilms.
The study aims to develop anti-bacterial human antibodies in vitro from patients who had recently undergone a
systemic infection by pathogenic bacteria and to use these antibodies as a tool for detecting bacteria in biofilms.
Methods: Lymphocytes were separated from whole blood of patients (n = 10) and stimulated with heat-killed bacteria
to produce antibodies in vitro. The specificity of antibodies in recognizing the bacteria against which they were
directed was evaluated by surface plasmon resonance system (SPR) and electron microscopy. The ulcer secretions
from patients with chronic and acute leg ulcers and healthy controls were analyzed by the SPR system and the
results were compared with culture studies.
Results: The produced antibodies recognized bacteria with high sensitivity (SPR). The antibodies against Enterococcus
fecalis bound specifically to the microorganism in a bacterial co-culture that was visualized by electron microscopy.
Conclusion: In the present work, a method for producing specific antibodies against bacteria is introduced to recognize
bacterial components in body fluids of patients suffering from pathogenic biofilms. This diagnostic technique may be
most useful in clinical microbiology and in the choice of antibiotics in the treatment of serious infections.
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Background
In late autumn 2008, a 49-year old woman died. She suf-
fered from type 1 diabetes, familial mediterranean fever,
peripheral neuropathy, and foot ulcers. In February
2008, she was admitted to the Department of Infectious
Diseases, University Hospital in Linköping for amputation
of her left foot and received piperacillin-tazobactam intra-
venously and a blood transfusion post-operatively (Fig. 1).
Despite this, her clinical status deteriorated critically
within one week and she developed acute liver and
renal insufficiency. The suggested diagnosis was
hemolytic uremic syndrome and the result of an allergic
reaction to piperacillin-tazobactam. She was treated
with plasmapheresis, corticosteroids, imipenem, and
metronidazole. The culture from the foot ulcer prior to
amputation revealed growth of Enterococcus fecalis (E.
fecalis) together with several gram-negative bacterial
strains. She recovered partially, but the renal function
was permanently destroyed and she was treated with
hemodialysis and released on March 11th 2008. On
March 24th, she was readmitted to the Department of
Infectious Diseases for fever, shivering, and diarrhea.
The blood cultures revealed growth of E. fecalis and
Staphylococcus aureus. She was transferred to the De-
partment of Cardiology, University Hospital in Linköp-
ing for mitral valve endocarditis and underwent surgery
for biological valve prosthesis. The antibiotic treatment was
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composed of meropenem, vancomycin, and clindamycin and
continued for 8 weeks. The heart valve culture revealed E.
fecalis. She was dismissed on June 5th 2008 with moxifloxa-
cin. She developed vomiting after 5 days at home and was re-
admitted on June 23rd. Blood cultures revealed growth of E.
fecalis again and she was treated with vancomycin. Echo-
cardiography showed a paravalvular leak that was
treated at the Department of Cardiology. On July 28th
2008, while still on the ward, she experienced sudden
temporary blindness. A computed tomography (CT) scan
did not show new pathologic signs that might explain the
symptom. Doktacillin was complementary to vancomycin
in the treatment. However, she developed hemolytic
anemia and antibiotic therapy was interrupted on August
8th. She suffered from anxiety, depression, severe heart
failure, pain, and loss of vision, but she had no fever. Blood
tests revealed a high sedimentation rate, anemia, high white
blood cell count, and a high level of C-reactive protein.
Blood cultures from eight different occasions yielded
no growth. Two short episodes of antibiotic therapy
with tigecycline and imipenem were interrupted due
to negative blood cultures. The symptoms were
judged as Mediterranean fever and she was trans-
ferred to the Department of Nephrology with high
dose of corticosteroids on October 1st. She died Octo-
ber 13th due to septic shock and E. fecalis grew in all
blood cultures that were taken before she died.
Persistent infection in biofilms has been the subject of
clinical studies since 1981. Biofilms are a collection of
microbes that adhere to surfaces by producing a matrix
that shields them from environmental elements. It has
been speculated that bacteria colonizing chronic wounds
are part of the highly persistent biofilms [1]. Molecular
analyses of chronic wound specimens revealed diverse
polymicrobial communities but it has been very difficult
to identify specific bacteria of the entire individual, espe-
cially strictly anaerobic bacteria, by culture methods [2].
Traditional culturing methods may be extremely biased
as a diagnostic tool as they select for easily cultured
organisms e.g. S. aureus, but not bacteria difficult to cul-
ture such as anaerobes [3]. The formation of bacterial
biofilms could lead to chronic inflammation. Detach-
ment of the biofilm enables bacteria to enter into the
blood stream, causing bacteremia and vascular embol-
ism [4]. The establishment of a non-cultural method
for analysis of infections may help to identify the key
bacteria that cause pathogenic biofilms [5–7]. Thus, it
is most important to identify the underlying causative
infectious agent in the symbiotic community of biofilms
in order to antagonize the development of a suitable en-
vironment for opportunistic pathogens and thereby im-
prove the wound healing process.
E. fecalis is a successful pathogen and is able to adapt
to the hostile environment to grow within the host and
has been shown to facilitate the survival of other bacteria
within the biofilms [8]. Therapy directed to eliminate
adherent gram-positive bacteria, such as E. fecalis, may
effectively destroy the biofilm by disturbing the growth
of rapid growing gram-negative bacteria [9–11].
The stimulation of memory cells from an isolated and
cultured lymphocyte population with antigens similar to
the subsequent infection could simplify the process of
antigen specific IgG secretion [12].
SPR is a real-time optical technique that can simultan-
eously determine the affinity of a protein for several li-
gands by using individual surfaces on a sensor chip [13].
As part of serial studies to identify the role of the
key bacteria in several associated diseases, this study
aims to:
– Develop anti-bacterial human antibodies in vitro
from patients who have been treated for systemic
infection.
– Immobilize the produced antibodies in a SPR system
and use the response to injected heat-killed pathogens
for assessment of specificity.
– Analyze the ulcer secretions from patients and
healthy volunteers by the SPR system and compare
the results to data from culture methods.
– To use these antibodies as an alternative tool for
detecting bacteria in biofilms.
Methods
Study subjects
The blood samples were collected at convalescence from
10 patients (described in the following section) who met
the study leader at Department of Infectious Diseases
and attended a follow-up visit within 4–8 weeks after
onset of systemic infection. The informed consent was
obtained and the samples were handled unidentified.
The ulcer secretion was collected from subjects (n = 24,
described in the following section). This material has
been presented previously [14]. The study was approved
Fig. 1 Chronic ulcer in a patient with persistent Enterococcus fecalis
infection and organ dysfunction in 2006
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by the local ethics committee at Linköping University
Hospital. All participants provided written consent
(03–322, M133-09).
Blood samples
Blood samples were gathered in EDTA tubes (Venoject
K2K, Terumo Europe NV, Leuven, Belgium) from patients
who had systemic infections caused by E. fecalis (male,
70 years old, septicemia), S. aureus (male, 26 years old, se-
vere periodontitis, ulcers and septicemia), Pseudomonas
aeruginosa (p. aeruginosa) (female, 35 years old, decubital
ulcer), Staphylococcus epidermidis (S. epidermidis) (female,
76 years old, prosthesis infection), Clostridium perfringens
(female, 75 years old, decubital abscess), Bacterioides fragi-
lis (male, 61 years old, perianal abscess and septicemia),
Prevotella oralis (male, 60 years old, severe periodontitis
and bacteremia), Escherichia Coli (E. coli) (female, 38 years
old, pyelonephritis) and Streptococcus sp. (78 years old
male, septicemia) at convalescence.
Ulcer secretion
Ulcer secretion was gathered from ten patients (8 women,
44–89 years of age, median 76 years old) with chronic leg
ulcers that had been stable for at least 6 months. The eti-
ologies of the ulcers were venous insufficiency or a com-
bined venous and mild arterial insufficiency determined
by clinical judgment and physiological measurements, i.e.,
toe and ankle pressure measurements. Cultures from
the ulcers revealed growth of several species of bacteria;
S. aureus, Enterobacter cloacae, P. aeruginosa, E. fecalis,
and Proteus mirabilis. Skin biopsies were taken from
the left arm of nine healthy volunteers (all women, 40–
60 years of age, median: 54 years) and were used as
controls. The ulcer secretion was collected within 24 h
after injury and the cultures from these healthy controls
were negative. Ulcer secretions were also collected from
5 patients within 2 weeks of operation for breast cancer
without any signs of metastasis (all women, 31–85 years
of age, median 64 years). Cultures revealed growth of S.
aureus in two cases and were negative in the rest of
these patients.
Collection of ulcer secretion
During a 24-h period, equal amounts of ulcer secretion
were collected by absorption using 1 cm2 of absorbent
material (Mepilex, Mölnly Health Care AB, Box 13080,
SE 40252, Göteborg, Sweden) placed under the dressing
and then transferred into a flask (scintillation vial
20 mL, Sarstedt AB, SE- 26151 Landskrona, Sweden)
containing 5 ml physiological sodium chloride (NaCl).
The sample was vortexed (Vortex-Genie, Scientific In-
dustries, Inc., New York, USA) and centrifuged at
3000 × g for 10 min. The supernatant was transferred
into tubes (Nunc Cryo Tube, Nunc Brand Products,
Denmark) and stored at −70 °C before analysis.
In vitro antibody production
Whole blood was diluted in 0.9 % NaCl solution in a
1:1 ratio and lymphocytes were isolated by density
gradient centrifugation using lymphoprep solution
(Axis-shield PoC, Oslo, Norway) upon centrifugation
at 1800 × g at 20 °C for 20 min. A clear distinct layer
of mononuclear cells containing lymphocytes was
carefully pipetted from the tube and cultured in L-15
medium (ATCC, Borås, Sweden), supplemented with
10 % fetal bovine serum (FBS; Sigma Aldrich,
Stockholm, Sweden), at 37 °C. The lymphocytes were
then stimulated with heat-killed E. fecalis (CCUG,
Gothenberg University, Sweden) at an optical density
(OD) of 1 and incubated at 37 °C for 3 weeks (Additional
file 1). After 3 weeks, the medium was collected and
centrifuged at 3000 × g for 10 min to pellet the cells.
The supernatant was filtered using 0.45 μm sterile
filters (Thermofisher Scientific, Stockholm, Sweden)
and centrifuged again using 100 KDa Amicon Micro-
con Centrifugal Filters (Millipore, Molsheim, France)
at 3000 × g for 60 min. Antibodies with molecular
weight over 100KDa were recovered from the filters by
pipetting and were stored at −70 °C until further use.
Electron microscopy examination of bacteria
A bacterial co-culture of E. fecalis, S. aureus and E. coli
was prepared by diluting the heat-killed bacteria in 1:100
ratio in PBS (pH 7.4, Apoteket, Linköping, Sweden), and
in vitro specific anti-E. fecalis antibodies were diluted
1:200 in PBS. The bacteria were incubated overnight
with anti- E. fecalis antibodies at 4 °C. Samples were then
incubated with nano gold-anti-human IgG antibodies
(Nanoprobes, New York, USA) diluted 1:10 in PBS for
2 h. The specimen was mounted on the formvar coated
copper grids and counter stained with 2 % Osmium tet-
roxide (Sigma-Aldrich, Sweden) and were analyzed
using TEM1230 Gantan Electron microscope (Linköping
University, Sweden).
Analysis of ligand-binding affinity using surface plasmon
resonance
The SPR measurements and ligand immobilization pro-
cedures were conducted at 760 nm in a fully automatic
Biacore 2000 instrument (GE-Healthcare GmbH, Upp-
sala, Sweden) equipped with four flow cells, and the
temperature was 25 °C in all experiments. The running
buffer was HBS-EP (0.01 M HEPES, 0.15 M NaCl,
3 mM EDTA, 0.005 % surfactant P20, pH 7.4) (GE-
Healthcare GmbH). Ligands were coupled to carboxy-
methylated dextran CM5 chips (GE Healthcare GmbH)
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by conventional carbodiimide chemistry using 200 mM N-
ethyl-N-(3 diethylaminopropyl) carbodiimide (EDC) and
50 mM N-hydroxysuccinimide (NHS). The activation time
was 7 min, followed by a 7 min ligand injection. Deactiva-
tion of the remaining active esters was performed by a
7 min injection of ethanolamine/hydrochloride, pH 8.5. A
flow rate of 5 μl/min was used during the immobilization
and measurement procedures. Antibodies developed
against bacteria were diluted 1:10 in 10 mM acetate buffer,
pH 4.5, below the isoelectric point of the protein, thus en-
hancing the electrostatic interactions between the dextran
matrix and the ligands. Anti-guinea pig IgG and anti-
human IgG (Sigma Aldrich) and heat-killed ATCC bacter-
ial strains (CCUG, Gothenburg, Sweden) were used as
controls. The contact time was 7 min, which resulted in
immobilization levels between 15000 and 40000 response
units (RU). Ulcer secretions were diluted 1:1 in PBS
(Apoteket AB, Umeå, Sweden). Injection of equal mixture of
1 M NaCl and 10 mM glycine, pH 2, followed by one
injection of borate pH 8.5, were used for regeneration
(1 min).
Statistics
Test performance of antibodies immobilized in SPR
system in identification of bacteria in ulcer secretions,
compared to culture results, were calculated using the
following formulas:
Negative Predictive value NPVð Þ
¼ Number of true negatives
Number of true negativesð Þ þ Number of false negativesð Þ
Positive Predictive value PPVð Þ
¼ Number of true positives
Number of true positivesð Þ þ Number of false positivesð Þ
Specificity
¼ Number of true negatives
Number of true negativesð Þ þ Number of false positivesð Þ
Sensitivity
¼ Number of true positivesðNumber of true positivesÞ þ Number of false negativesð Þ
Results
The specificity of the developed antibodies was studied
by the assessment of binding affinity of heat-killed bac-
terial strains to antibodies immobilized in the SPR sys-
tem (Table 1). The SPR analysis of ulcer secretions using
biosensor chips immobilized with antibodies developed
against P. aeruginosa, S. aureus, E. fecalis, and S. epider-
midis determined that S. aureus was found in 6/10 cul-
tures from chronic ulcers and there was binding affinity
to antibodies against S. aureus in 5/6 SPR analyses. S.
aureus grew in 2/5 ulcer secretions from patients that
had undergone breast cancer surgery and there was a
binding affinity to S. aureus antibodies in both cases. E.
fecalis grew in 1/10 ulcer secretion from chronic ulcers,
however there was a positive binding to antibodies
against E. fecalis in 3/10 specimens. There was no bind-
ing affinity to antibodies against E. fecalis in the ulcer se-
cretions from healthy staff or patients who underwent
breast cancer surgery (Table 2).
There was no growth of bacteria in cultures of ulcer
secretions from the forearm in the healthy staff post bi-
opsy. However, there was a positive binding to anti-
bodies against S. epidermidis in 7/9 specimens.
Test performance for detection of pathogens in ulcer
secretions by SPR using in vitro antibodies, compared
with conventional culture techniques, showed results for
S. aureus with 87.5 % sensitivity, 100 % specificity, posi-
tive predictive value (PPV) 100 % and negative predictive
value (NPV) 94 % and for E. fecalis with 100 %



















S. aureus 250 0 0 0 0 0 0 0 0
S. epidermidis 0 103 0 0 0 0 0 0 0
E. fecalis 0 0 244 0 0 0 0 0 0
P. aeruginosa 0 0 0 36.4 0 0 0 0 0
C.perfringens 0 0 0 0 31.8 0 0 0 0
B. fragilis 0 0 0 0 0 230.1 0 0 0
P. oralis 0 0 0 0 0 0 570 0 0
E. coli 0 0 0 0 0 0 0 185.5 0
Streptococcus sp. 0 0 0 0 0 0 0 0 278.3
Anti-guinea pig IgG 0 0 0 0 0 0 0 0 0
Anti-human IgG 279 140 646.5 439 342.3 75.8 809.2 234.6 461.1
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sensitivity, 91.3 % specificity, PPV 33.3 % and NPV
100 % (Tables 2 and 3).
The electron microscope images showed a specific
interaction of anti-E. fecalis antibodies to E. fecalis in a
monoculture preparation but not in a monoculture
preparations of S. aureus or E. coli (Figs. 2 and 3). Fur-
thermore, in a bacterial co-culture preparation contain-
ing the three bacterial strains (E. fecalis, S. aureus, and
E. coli), anti-E. fecalis antibodies bound specifically only
to the surface of few cocci (shown in arrows) but not to
the other bacteria (Additional file 2).
Discussion
In the present work, the case of a middle-aged
woman with persistent infection caused by E. fecalis
and the ultimate outcome motivated a development
of a non-culture bacterial detection method in man-
agement of complicated patient cases. The objective
Table 2 Affinity of ulcer secretions to the immobilised antibodies in SPR system and the correlation to culture results
Ulcer
secretion
Culture results Binding to the produced antibodies in SPR system
Anti-P. aeruginosa Anti-S. aureus Anti-E. fecalis Anti-S. epidermidis
Ulcer secretion from patients with chronic ulcer
1 Staphylococcus aureus + Enterobacter cloacae negative positive negative positive
2 Staphylococcus aureus + Echerichia coli negative positive negative negative
3 Staphylococcus aureus + Pseudomonas aeroginosa negative positive negative negative
4 Staphylococcus aureus negative negative negative negative
5 Proteus mirabilis + coagulase negative staphylococcus negative negative positive positive
6 negative negative negative negative negative
7 Pseudomonas aeruginosa + Enterococcus fecalis positive negative positive negative
8 Staphylococcus aureus negative positive negative positive
9 Staphylococcus aureus negative positive positive positive
10 negative negative negative negative negative
Ulcer secretion from patients post breast cancer surgery
1 negative negative negative negative positive
2 negative negative negative negative positive
3 negative negative negative negative positive
4 Staphylococcus aureus negative positive negative negative
5 Staphylococcus aureus negative positive negative negative
Ulcer secretion from healthy volunteers post skin biopsy in fore-arm
1 negative negative negative negative positive
2 negative negative negative negative negative
3 negative negative negative negative negative
4 negative negative negative negative positive
5 negative negative negative negative positive
6 negative negative negative negative positive
7 negative negative negative negative positive
8 negative negative negative negative positive
9 negative negative negative negative positive
Table 3 Test performance of binding to the produced antibodies immobilized in SPR system in comparison to conventional ulcer
secretion cultures
SPR/culture False positive (SPR) True positive (culture) False negative (SPR) True negative (culture) Total
Staphylococcus aureus 0 7 1 16 24
Enterococcus fecalis 2 1 0 21 24
Sensitivity for Staphylococcus aureus was 87.5 %, specificity 100 %, PPV 100 % and NPV 94 %. Sensitivity for Enterococcus fecalis was 100 %, specificity 91.3 %, PPV
33.3 % and NPV 100 %
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was to further increase the knowledge regarding the
detection of life-threatening silent infections. Anti-
bacterial in vitro human antibodies were developed
from patients at convalescence and immobilized in a
SPR system and used for assessment of presence of
bacteria in ulcer secretions. Compared to culture re-
sults, the produced antibodies could recognize the
microorganism with quite high test performance.
In the field of medical diagnostics and the treatment of
patients, the practitioner only has a narrow perspective on
the factual preconditions of disease development and the
true origin of the symptoms. Diagnostic tools give the
clinician valuable insight into the characteristics of the
pathology and help in choosing the best path of interven-
tion [15]. Previous medical records are seldom studied in
detail and it is quite acceptable for medical personnel to at-
tempt to treat the complications of chronic inflammatory
processes by managing the symptoms and organ fail-
ures temporarily [16]. However, a great number of dif-
ferent infectious agents may contribute to the patient’s
sicknesses and sometimes the main cause is identified
and successfully treated [17–20]. Yet, the reasons for
and circumstances in which there is a transition from
acute to chronic infection and inflammation are still
not well understood. To better understand this transi-
tion, the relevant factors and components have to be
characterized and identified.
An acute inflammatory process is the immediate result
of the body’s recognition of and reaction to a foreign
pathogen and the body’s attempt to eliminate the in-
truder [21]. A prolonged chronic inflammatory process
might depend on the persistence of the pathogens be-
cause of the nature of the invaders and/or the inability
of the host to eliminate this intruder [22]. The constant
host-microbe interactions are exhausting to the host
body [23]. During an acute inflammatory response, the
natural defensive reaction is more devastating to the
body than the invasion itself. The contrary occurs during
chronic inflammation, where the overgrowth of an
otherwise hidden infection might cause septicemia,
micro-circulatory defects, ischemia, and chronic organ
failure [24]. Chronic sepsis and multiple organ failure
can be consequences of a prolonged chronic inflamma-
tory process [25]. In many cases, the source of inflam-
mation is known, however with poor prospects of
eliminating it. Bacteria in the planktonic shape might
often be sensitive to immune responses and antibiotics,
whereas the coexistence of bacteria in a biofilm makes
them resistant to antibiotics. This also contributes to the
development of new drug resistant strains [26, 27].
Therefore, it is most important to find out the reason
why the infection succeeds in persisting, before it be-
comes invasive. As a model of chronic organ injury, we
have investigated patients with chronic ulcers and have
tried to clarify why some ulcers do not heal [28–31].
Periodontitis has been studied in our group with special
focus on the role of P. gingivalis in chronic inflammatory
diseases [32]. We have shown that stimulation of lym-
phocytes from a patient who suffered from periodon-
titis with P. gingivalis caused maturation of cells into
antibody secreting, CD38-expressing plasma cells, 2–3
weeks after stimulation. The results from SPR analysis
of crevicular fluid samples from patients with peri-
odontitis and controls correlated significantly with
RT-PCR results (p >0.05) [33].
Although the recent advances in science have suc-
ceeded in development of highly sensitive and specific
nucleic-acid based methods, PCR analysis was not per-
formed on the ulcer secretion that was assessed in the
present study. The production of antibodies in vitro
against bacteria was not meant to replace a highly
Fig. 2 Co-culture of three bacterial strains: Staphylococcus aureus,
Enterococcus fecalis, and Escherichia coli. Anti- Enterococcus fecalis
antibodies incubated with the co-culture bound to some cocci but
not to the other cocci or rods (white arrows). This interaction was
visualized by electron microscopy by adding gold labled anti human
IgG antibodies to the medium
Fig. 3 Co-culture of Enterococcus fecalis and Staphylococcus aureus
incubated with anti-Enterococcus fecalis antibodies and visualized by
electron microscopy. Please note the antibodies covering some cocci
in the co-culture of two bacterial strains (white arrow)
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technologic PCR method in detection of bacteria. We
aimed to develop a method to specifically prove the
presence of pathogenic bacteria. Upon detection of
such bacteria we have recently succeeded to treat sev-
eral complicated polymicrobial infections focused on
gram-positive bacteria with antibiotic therapy including
ampicillin or vancomycin [11]. This might have an im-
pact on decreasing extended spectrum beta-lactamase
(ESBL)-producing organisms that colonize chronic
wounds. The finding that the SPR method did not de-
tect culture verified bacteria in two ulcer secretions
(Table 2), may be due to a low sensitivity of the SPR
method. Though we have produced the antibodies at
convalescence from lymphocytes of patients that had
undergone infection with pathogenic bacteria, another
reason for false negative result in two cases might be
that the antibodies detect the pathogens with specified
epitopes. This mechanism is one of our goals to be in-
vestigated in future studies.
Conclusion
Biofilms are poorly investigated as a source of chronic
inflammation and multi-resistant bacteria in biofilms
and chronic organ dysfunction are huge clinical prob-
lems. The lack of scientific evidence demonstrating a
near association between silent organ dysfunction and
an infectious focus is a major problem in clinical medi-
cine. We have attempted to produce antibodies using
memory cells of patients that had undergone a severe in-
fection caused by a pathogen in order to detect patho-
gens in polymicrobial environments. In future studies,
we aim to identify and produce antibodies against epi-
topes that reflect the presence of pathogenic key bacteria
in biofilms.
Additional files
Additional file 1: Microscopic analysis of host lymphocytes after stimulation
with heat killed E. fecalis. Lymphocytes cultured in L-15 medium with 10 %
FBS were stimulated with the same bacteria which had previously infected
the donor and immune response to pathogenic stimulation was observed at
40X resolution in light microscopy. Morphological changes were observed in
activated lymphocytes. (JPG 375 kb)
Additional file 2: Electron microscopic image of Escherichia coli
incubated with Anti-BCG antibodies and gold labled anti human IgG
secondary antibodies. (JPG 4702 kb)
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